Instalab
logoInstalab

Hereditary Hemochromatosis DNA Mutation Analysis

Check inherited susceptibility to iron overload before symptoms develop, or help explain iron results that are already high.
4.9 (4,963 reviews)
Tested by Quest Diagnostics
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Collect your sample
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Hereditary Hemochromatosis DNA Mutation Analysis test?

This test is most useful if any of these apply to you.

an adult with hemochromatosis in your family
A close relative has confirmed inherited iron overload, and you want to check whether you inherited a similar risk.
trying to explain persistently high iron results
Your transferrin saturation stays high, especially alongside raised ferritin, and you want to check a common inherited cause.
curious about your inherited iron risk
You want to understand genetic susceptibility, while recognizing that ancestry alone doesn't make screening necessary.
investigating joint or liver problems with abnormal iron tests
Your symptoms and iron results raise concern about overload, and you want to clarify whether common gene variants contribute.

3 biomarkers included

  • HFE C282YHFE helps control iron absorption. This test identifies its best-established iron-overload risk variant, whose copy number anchors interpretation of the other two results.Why it mattersTwo C282Y copies confer a strong susceptibility to progressive iron overload; iron studies show whether excess iron has accumulated.
  • HFE H63DDistinguishes a C282Y/H63D combination from a single C282Y finding and adds context for mild changes in blood iron measurements.Why it mattersH63D alongside C282Y can accompany mild iron loading; substantial overload warrants checking additional liver conditions or genetic causes.
  • HFE S65CIdentifies a less common variant studied for possible effects on iron handling, adding context to the C282Y and H63D pattern and measured iron stores.Why it mattersSmall studies link S65C to mild iron loading, but its contribution to clinically significant disease remains uncertain.

About Hereditary Hemochromatosis DNA Mutation Analysis

Hereditary hemochromatosis can make your gut absorb more iron than you need. Over time, excess iron can damage your liver, pancreas, joints, and sometimes your heart. This panel checks three inherited variants in HFE. HFE is a gene that helps control iron absorption. Finding a variant can identify susceptibility before symptoms develop, but it doesn't establish that iron has accumulated.

The combination matters. Two copies of C282Y carry a much stronger risk than one copy paired with H63D or S65C. Reading the genetic results alongside your iron studies helps distinguish a tendency that needs monitoring from iron overload that may need treatment.

What This Panel Reveals

The HFE protein helps regulate hepcidin production. Hepcidin is a liver hormone that limits iron absorption. Two C282Y copies can disrupt this control and account for most HFE-related hemochromatosis in people of Northern European ancestry. Many people with this genetic pattern never develop organ damage.

H63D has a weaker association with iron abnormalities. In an Australian population study, it was associated with higher transferrin saturation without a corresponding rise in average ferritin. One C282Y plus one H63D can accompany mild iron loading, but substantial overload is uncommon. Alcohol-related liver disease, fatty liver, and other genetic factors can affect how the pattern develops.

S65C adds information about another HFE variant. Small human studies have reported mild or moderate iron loading in some people carrying it, but its role in clinically significant disease remains unestablished. C282Y testing has an established diagnostic role; the evidence does not support treating all three variants as equivalent causes of disease. Specialist genetic guidelines do not recommend S65C as a routine diagnostic target.

How to Read Your Results Together

Ferritin helps estimate your stored iron. Transferrin saturation measures how much of your blood's iron-carrying capacity is occupied. These are separate blood measurements, not results included in this DNA panel. Interpret the full variant pattern with both.

Your resultsWhat the pattern suggests
Two C282Y copies with normal ferritinInherited susceptibility with no ferritin elevation yet. High transferrin saturation can appear before ferritin rises.
Two C282Y copies with persistently high transferrin saturation and raised ferritinThe typical laboratory pattern of HFE-related hemochromatosis. It supports assessment of iron overload and liver health.
One C282Y plus one H63D with raised iron measurementsPossible mild iron loading. Substantial overload needs assessment for additional causes and, when appropriate, confirmation of liver iron.
One C282Y plus one S65CA possible mild iron-loading association with less certain clinical significance. Ferritin and transferrin saturation determine whether an iron abnormality is present.
A single variant, or H63D without C282Y, with high ferritinThis genetic result alone usually doesn't explain substantial iron overload. Other causes of high ferritin need consideration.
High ferritin with normal transferrin saturation, whatever your genetic resultInflammation, fatty liver, or alcohol-related injury may explain the ferritin. Some less common forms of iron overload also have this pattern.
None of the three variants detected, but iron measurements stay highThe common C282Y-related cause is unlikely. Acquired iron overload and rarer inherited causes remain possible.

Risk also depends on age and sex. In a Melbourne cohort followed for about 12 years, documented iron-related disease was present in about 28% of men with two C282Y copies and about 1% of women. The definition included raised liver enzymes and characteristic joint findings as well as severe liver disease. Menstrual blood loss partly explains the sex difference, and iron stores can rise after menopause.

Later-life risks are substantial in some people. A British population study estimated that about one in five men with two C282Y copies would have a liver disease diagnosis by age 80, compared with about one in twelve men carrying neither C282Y nor H63D. A separate analysis estimated primary liver cancer risk by age 75 at about 7% versus less than 1%. These are population estimates, not predictions of your outcome after diagnosis and treatment.

A Danish study also found higher diabetes risk among people with two C282Y copies whose ferritin and transferrin saturation were normal at a single measurement. That association doesn't establish that blood removal benefits people whose iron stores are normal.

What to Do with Your Results

Use your genetic result to guide assessment of your iron measurements and family history. Confirmed iron overload may call for supervised blood removal and assessment of liver scarring. Treatment decisions for H63D or S65C combinations require evidence of excess iron; the genetic label alone is insufficient. Adult close relatives of someone with confirmed HFE-related hemochromatosis can benefit from family testing.

Alcohol intake and abdominal fat also affect liver risk. Among men with two C282Y copies, one study estimated liver scarring by age 80 in about 15% with a high waist-to-hip ratio versus about 4% with a normal ratio. This was an observational association, not a trial of weight loss.

When Results Can Be Misleading

Ferritin can rise with inflammation, recent illness, fatty liver, or alcohol-related injury, sometimes without excess tissue iron. Those conditions can also coexist with inherited iron overload. Avoid assuming that a mild genetic finding explains every abnormal iron result.

A negative result covers only the variants tested. This panel does not examine every HFE variant or other iron-regulating genes. Its ability to identify an inherited cause varies with ancestry because C282Y is much more common in Northern European populations.

Frequently Asked Questions

References

12 studies
  1. Katrina J. Allen, Lyle C. Gurrin, Clare C. Constantine, Nicholas J. Osborne, Martin B. Delatycki, Amanda J. Nicoll, Christine E. Mclaren, Melanie Bahlo, Amy E. Nisselle, Chris D. Vulpe, Gregory J. Anderson, Melissa C. Southey, Graham G. Giles, Dallas R. English, John L. Hopper, John K. Olynyk, Lawrie W. Powell, Dorota M. GertigNew England Journal of Medicine2008
  2. Mitchell R. Lucas, Janice L. Atkins, Luke C. Pilling, Jeremy D. Shearman, David MelzerBMJ Open2024
  3. Janice L. Atkins, Luke C. Pilling, Jane a. H. Masoli, Chia-ling Kuo, Jeremy D. Shearman, Paul C. Adams, David MelzerJAMA2020
  4. Mathis Mottelson, Jens Helby, Børge Grønne Nordestgaard, Christina Ellervik, Thomas Mandrup-poulsen, Jesper Petersen, Stig Egil Bojesen, Andreas GlenthøjBMJ2024
  5. Elizabeth D. Morrison, David J. Brandhagen, Pradyumna D. Phatak, James C. Barton, Edward L. Krawitt, Hashem B. El-serag, Stuart C. Gordon, Mark V. Galan, Bruce Y. Tung, George N. Ioannou, Kris V. KowdleyAnnals of Internal Medicine2003

Hereditary Hemochromatosis DNA Mutation Analysis

$385
Includes 3 biomarkers:
HFE C282YHFE H63DHFE S65C
FSA/HSA eligible
No Rx needed
HIPAA compliant